Lilian Wan is a Principal with Lilly Asia Ventures. Previously, Lilian was an Associate Director at HSBC Global Asset Management. Prior to that, Lilian served as the lead analyst in healthcare with BOCOM International, Equity Research Associate with BofA Merrill Lynch, Jefferies and CICC. Lilian holds a M.P.H degree from Harvard T.H. Chan School of Public Health, a Master's Degree in Economics from Peking University and a Bachelor's Degree in Biotechnology from Nanjing university.